Clinical trial
A Randomised, Double Blind Placebo-controlled Trial Evaluating the Medical Food Synbiotic SBD121, Versus Placebo for the Clinical Dietary Management of Early Rheumatoid Arthritis.
NCT06005220 is registered in ClinicalTrials.gov with Solarea Bio, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomised, Double Blind Placebo-controlled Trial Evaluating the Medical Food Synbiotic SBD121, Versus Placebo for the Clinical Dietary Management of Early Rheumatoid Arthritis.
- Lead sponsor
- Solarea Bio, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2023
- Completion date
- October 6, 2025
- Enrollment
- 143 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis